West Pharmaceutical Q3 2026 Earnings Preview

West Pharmaceutical (WST) is scheduled to announce Q3 earnings results on Thursday, October 29th, before market open. - The consensus EPS Estimate is $2.20 (+12.2% Y/Y) and the consensus Revenue Estimate is $826.55M (+2.7% Y/Y). - Over the last 2 years, WST

West Pharmaceutical (WST) is scheduled to announce Q3 earnings results on Thursday, October 29th, before market open. – The consensus EPS Estimate is $2.20 (+12.2% Y/Y) and the consensus Revenue Estimate is $826.55M (+2.7% Y/Y). – Over the last 2 years, WST

Leave a Reply

Your email address will not be published. Required fields are marked *